• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | [email protected]

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2025 Annual Meeting
    • 2024 Annual Meeting Recap
    • Call For Abstracts
    • Past Posters
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
    • FSAPAC Donors for 2025
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)

2022 FSA Podium and Poster Abstracts

2022 FSA Podium and Poster Abstracts

P004: IATROGENIC SUPERIOR VENA CAVA OBSTRUCTION PRIOR TO CARDIAC SURGERY
Christina C Moore, MD; Sofia A Lifgren, MD; Yiliam Rodriguez-Blanco, MD; University of Miami/Jackson Memorial Hospital

Introduction: Superior Vena Cava(SVC) Syndrome(SVCS) results from partial or complete obstruction of the SVC. Iatrogenic causes of SVCS are increasing in frequency with 71% of nonmalignant cases attributed to intravascular devices like tunneled dialysis catheters(TDC)[i]. SVCS presents with edema, dysphagia, dyspnea, chest pain, and elevated central venous pressures(CVP) due to impaired venous drainage. Yet despite severe obstruction, overt symptoms may be absent with sufficient compensation. The reported prevalence of asymptomatic SVC obstruction varies greatly (3%1 - 82%[ii]). The authors present a case of iatrogenic SVC obstruction from a TDC thrombus in a patient requiring cardiac surgery. Thrombectomy revealed severe underlying SVC stenosis, but the patient never developed SVCS.

CaseReport: 44-year-old female with end stage renal disease(ESRD) presented with acute endocarditis of the mitral(MV) and tricuspid valves(TV). Transesophageal echocardiogram(TEE) revealed large vegetations on the MV and TV and a nearly occlusive thrombosis of the SVC at the site of a TDC (FIGURE 1). Despite significant occlusion, the patient exhibited no symptoms of SVCS. She was deemed a surgical candidate due to severe valvular dysfunction.

The patient remained hemodynamically stable during induction of general anesthesia. Central venous access(CL) was obtained carefully through the right internal jugular vein (IJ). CVP ranged from 17-23mmHg. Cardiopulmonary bypass(CPB) was initiated, and the MV was replaced while the TV was repaired. The SVC thrombus was removed to improve venous drainage. The patient was weaned from CPB uneventfully requiring minimal vasopressor support. After CPB cessation, CVP was >30mmHg despite maintenance of preoperative mean arterial pressures (~70mmHg). TEE demonstrated underlying stenosis of the SVC(FIGURE 2). However, the patient did not exhibit clinical signs of SVCS. The right IJ CL was replaced with a femoral CL. The patient was transferred to the intensive care unit with her head elevated. She was extubated uneventfully on postoperative day one and discharged without ever developing SVCS.

Discussion: SVCS after cardiac surgery is rare. The authors found two cases attributed to malposition of the SVC cannula during MV repair where both patients exhibited overt SVCS[iii],[iv]. However, patients with ESRD and >50% SVC stenosis from TDCs are symptomatic only 18% of the time3. This case demonstrates iatrogenic SVC stenosis from a TDC. Due to chronic SVC obstruction, the patient failed to exhibit SVCS even when thrombectomy revealed severe underlying SVC stenosis.

[i] Rice TW, Rodriguez RM, Light RW. The Superior Vena Cava Syndrome: Clinical Characteristics and Evolving Etiology. Medicine 2006; 85(1): 37-42.

[ii] Labriola L, Seront B, Crott R, Borceux P, Hammer F, Jadoul M. Superior vena cava stenosis in haemodialysis patients with a tunneled cuffed catheter: prevalence and risk factors. Nephrol Dial Transplant 2018. 33(12): 2227-2233.

[iii] Heppel D, Grapow M, Reuthebuch O, Bolliger D, Fassl J. Superior Vena Cava Syndrome Following Mitral Valve Repair. Journal of Cardiothoracic and Vascular Anesthesia 2018; 32(2): 938-941.

[iv] Ellison MB, Statler A, Henrickson RE, Graff J, Sloyer D, Khan MAA, Hayanga HK, Ellison PR. Iatrogenic Superior Vena Cava Syndrome after Cardiopulmonary Bypass Diagnosed by Intraoperative Echocardiography. Case Rep Anesthesiol 2020; 2020: 8813065.

Copyright © 2025 · Florida Society of Anesthesiologists · All Rights Reserved